NEW: World Trade TARIFFS Simulator!
NEW: 2023 Data and Complexity Rankings
Sign In
Pricing

300341 (Harmonized System 2017 for 6-digit)

2023
World Trade $19.3MRnk 5092 / 5380
2023
Top Exporter | Top Importer $12.4M | $12.4MChina | Japan
2023
Product Complexity -0.89Rnk 4287 / 5381
2022 - 2023
Export Growth (CAGR) 67.6%Rnk 74 / 5380
2023
Share of World Trade <0.01%Rnk 5092 / 5380

About

Overview This page contains the latest trade data of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. In 2023, Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were the world's 5092nd most traded product, with a total trade of $19.3M. Between 2022 and 2023 the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale grew by 67.6%, from $11.5M to $19.3M. Trade in Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale represent 0.000085% of total world trade.

Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....

Exports In 2023 the top exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale  were China ($12.4M), India ($2.76M), Oman ($650k), Italy ($645k), and Egypt ($630k).

Imports In 2023 the top importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($12.4M), United States ($2.97M), Lebanon ($650k), Malawi ($490k), and Finland ($454k).

Ranking Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale ranks 4287th in the Product Complexity Index (PCI).

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2023)China$12.4M
Top Destination (2023)Japan$12.4M

In 2023 Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were the world's 5092nd most traded product (out of 5,380).

In 2023, the top exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were China ($12.4M), India ($2.76M), Oman ($650k), Italy ($645k), and Egypt ($630k).

In 2023, the top importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($12.4M), United States ($2.97M), Lebanon ($650k), Malawi ($490k), and Finland ($454k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2023)
[Click to Select a Country]

Importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2023)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2022 -  2023)China$4.97M
Top Destination Growth (2022 -  2023)Japan$4.97M

Between 2022 and 2023, the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale grew the fastest in China ($4.97M), India ($1.49M), Oman ($650k), Italy ($348k), and Egypt ($342k).

Between 2022 and 2023, the fastest growing importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($4.97M), United States ($1.8M), Lebanon ($650k), Malawi ($442k), and Iraq ($403k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2022 - 2023)

Importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2022 - 2023)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale.

In 2023, market concentration measured using Shannon Entropy, was 2.04. This means that most of the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale are explained by 4 countries.

Explore Visualizations

Value of Exports in Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale

Net Trade

TOP NET EXPORTER (2023)China$12.4M
TOP NET IMPORTER (2023)Japan$12.2M

This map shows which countries export or import more of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. Each country is colored based on the difference in exports and imports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale during 2023.

In 2023, the countries that had a largest trade value in exports than in imports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were China ($12.4M), India ($2.76M), Oman ($647k), Italy ($642k), and Egypt ($630k).

In 2023, the countries that had a largest trade value in imports than in exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($12.2M), United States ($2.8M), Germany ($387k), Denmark ($279k), and Belgium ($181k).

Net Trade (2023)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale.
It is possible to select the main countries that export or import Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2023)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms